Acquisition further advances CVS Health’s care delivery strategy for consumers
CVS Health® (NYSE: CVS) and Oak Street Health (NYSE: OSH) have entered into a definitive agreement under which CVS Health will acquire Oak Street Health in an all-cash transaction at $39 per share, representing an enterprise value of approximately $10.6 billion.
Oak Street Health is…
Veterans Affairs has announced the winners of the Mission Daybreak Grand Challenge, part of a 10-year strategy to end veteran suicide through a comprehensive, public health approach.WHY IT MATTERS
Preventing Veteran suicide is the VA’s top clinical priority, according to an announcement about the Mission Daybreak winners.
The challenge was launched last year…
SA Health has started a 24/7 remote health monitoring service in rural and regional South Australia.Funded by Country SA Primary Health Network, the service is being provided by the Integrated Cardiovascular Clinical Network of the Rural Support Service.
HOW IT WORKS
The free service, which is available to individuals aged 15 and over…
Melissa Mooney, Director of eCOA Solutions Engineering at IQVIAIn the US alone, an estimated 1.9 million new cases of cancer were diagnosed in 2022, positioning oncology as a key subject of clinical research. Throughout oncology trial development, it is important that stakeholders acknowledge that only patients can fully understand the impact of treatment on their lives. Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. When evaluating the risks and benefits of treatment, they want to know whether the side effects are tolerable for patients and how these treatments could be improved from the patient’s…
Continue Reading
Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked epidemics plaguing healthcare: prescription drug abuse.
Before Covid-19 diverted attention away from this problem, President Trump signed on to the SUPPORT for Patients and Communities Act of 2018, instating sweeping legislation for initiatives to address the opioid epidemic. The bill, among other initiatives, requires electronic prescriptions for controlled substances (EPCS) for any covered part D drug. Although the official start of the mandate was delayed two years to January 1, 2023, the importance of this federal intervention cannot be…
The Health Transformation Alliance (HTA), a group of nearly 60 large employers, announced Thursday it is partnering with pediatric behavioral health company Cognoa for its diagnostic device for autism.
HTA is a cooperative of self-insured employers, including Walgreens, CocaCola, Verizon and American Express. Palo Alto, California-based Cognoa, meanwhile, is a developer of AI-based technologies for early diagnosis of children with developmental and behavioral health conditions. Its Canvas Dx product is authorized by the Food and Drug Administration and assists healthcare providers in diagnosing autism spectrum disorder for children ages 18 months through 72 months. The product is the first of its sort…
Talaris Therapeutics aimed to transform solid organ transplants with a cell therapy that replaces anti-rejection drugs patients need for the rest of their lives. But after clinical trial setbacks, the biotech has decided to end two kidney transplant studies. Although a separate test of its experimental therapy is continuing in a rare autoimmune condition, Talaris has commenced a restructuring plan that it said could culminate in a merger or sale of the company.
The restructuring announced Thursday will lead to the layoff of about one-third of Talaris’s staff. As of the end of the third quarter of 2022, the Louisville, Kentucky-based biotech…
What You Should Know:– Deloitte Centre for Health Solutions releases its thirteenth annual report, ‘Seize the Digital Momentum: Measuring the return from pharmaceutical innovation 2022’ that explores the performance of the biopharmaceutical industry (bio Pharma) and its ability to generate returns from investment in innovative new medicines.– Since 2021, much of the world has successfully adjusted to life where COVID-19 is more endemic as vaccines and treatments reduced the risk and severity of illness, however geopolitical turmoil and a global cost-of-living crisis have continued to drive serious instability in the health landscape.Pharmaceutical Innovation – Trends and Insights At a GlanceThis is…
Continue Reading
A new American Health Information Management Association study aimed at finding a better understanding of the operational realities of how social determinants of health data is used in real-world healthcare scenarios, finding a lack of standardization, insufficient training and limited cross-sector use.WHY IT MATTERS
The study, conducted by NORC at the University of Chicago, surveyed more than 2,600 AHIMA members and nonmembers from a pool of 41,000 potential respondents between August 24 and September 9, 2022.
Respondents included coding professionals; managers, directors and vice presidents of health information management; HIM team members and executives.
SDOH data can offer additional insights to help enrich clinical decision-making…
As burnout among healthcare workers continues to be a major concern, the use of artificial intelligence, EHRs and other automation tools may be able to have a positive impact on hospitals and health systems.When it comes to artificial intelligence, some legal issues arise. That’s why we interviewed Carly Koza, an authority on this topic and Buchanan Ingersoll & Rooney associate. Buchanan Ingersoll & Rooney is a national law firm with 450 attorneys and government relations professionals across 15 offices representing companies including 50 of the Fortune 100.
Koza discusses what healthcare provider organizations should prepare for when it comes to growing AI…
